IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking

Journal of Immunology

Volumn 168, Issue 7, 2002, Pages 3195-3204

  Dufour, Jennifer H ^a   Dziejman, Michelle ^a   Liu, Michael T ^a   Leung, Josephine H ^a   Lane, Thomas E ^a   Luster, Andrew D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN LEVEL; CELL TRANSPORT; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE DISRUPTION; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TH1 CELL; VIRUS REPLICATION;

EID: 0036533663     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.7.3195     Document Type: Article

References (70)

1. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins
2. Constitutive expression of IP-10 in lymphoid organs and inducible expression in T cells and thymocytes
3. Biochemical characterization of a γ interferon-inducible cytokine (IP-10)
4. Identification of CRG-2: An interferon-inducible mRNA predicted to encode a murine monokine
5. A macrophage LPS-inducible early gene encodes the murine homologue of IP-10
6. Detection of a γ interferon-induced protein IP-10 in psoriatic plaques
7. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation
8. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
9. + T cells are increased in multiple sclerosis and their ligands MIP-1 and IP-10 are expressed in demyelinating brain lesions
10. The interferon-γ inducible CXC chemokines IP-10, Mig, and I-TAC are differentially expressed by human atheroma-associated cells: Implications for lymphocyte recruitment in atherogenesis
11. CXCR3 and CCR5 ligands in rheumatoid arthritis synovium
12. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection
13. CXCR3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection
14. Chemokines in inflammatory bowel disease mucosa: Expression of RANTES, macrophage inflammatory protein (MIP)-1α, MIP-1β, and γ-interferon-inducible protein-10 by macrophages, lymphocytes, endothelial cells, and granulomas
15. Chemokines in viral meningitis: Chemotactic cerebrospinal fluid factors include MCP-1 and IP-10 for monocytes and activate T lymphocytes
16. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions
17. Expression of IFN-inducible protein-10 in chronic hepatitis
18. Chemokine receptor specific for IP10 and Mig: Structure, function, and expression in activated T-lymphocytes
19. CCR5 is characteristic of Th1 lymphocytes
20. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions
21. Lymphocyte homing and homeostasis
22. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon
23. CXCR3 chemokine receptor distribution in normal and inflamed tissues: Expression on activated lymphocytes, endothelial cells, and dendritic cells
24. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis
25. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia
26. CXCR3 expression and activation of eosinophils: Role of 1FN-γ-inducible protein-10 and monokine induced by IFN-γ
27. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity
28. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells
29. + T cells, and natural killer-type cells in human thymus
30. + hematopoietic progenitors from human cord blood induced by granulocyte-macrophage colony-stimulating factor: Chemotaxis and adhesion induced by its ligands, interferon γ-inducible protein 10 and monokine induced by interferon γ
31. HuMig: A new human member of the chemokine family of cytokines
32. Interferon-inducible T cell alpha chemoattractant (1-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3
33. The murine chemokine CXCL11 (IFN-inducible T cell α chemoattractant) is an IFN-γ- and lipopolysaccharide-inducible glucocorticoid-attenuated response gene expressed in lung and other tissues during endotoxemia
34. The IP-10 chemokine is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection
35. Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-γ with patterns of tissue expression that suggest nonredundant roles in vivo
36. The CXC chemokine Mig is highly expressed in the papillae of psoriatic lesions
37. + T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis
38. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease
39. Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis
40. T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-γ-induced chemokine Mig
41. Donor-derived IP-10 initiates development of acute allograft rejection
42. Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFNγ over IL-4 responses
43. IFN-γ-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy
44. Cooperative interaction between interferon (IFN) stimulus response element and κB sequence motifs controls IFNTγ and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter
45. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation
46. + T cells and RANTES in virus-induced central nervous system inflammation and demyelination
47. CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination
48. + T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity
49. The JHM strain of mouse hepatitis virus induces a spike protein-specific Db-restricted cytotoxic T cell response
50. Mechanism and regulation of immunoglobulin isotype switching
51. Chemokine expression in trinitrochlorobenzene-mediated contact hyper-sensitivity
52. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion
53. Targeted disruption of the interferon-γ receptor 2 gene results in severe immune defects in mice
54. + T cells during the elicitation of contact hypersensitivity
55. Regulation of chemokine gene expression by contact hypersensitivity and by oral tolerance
56. IFN-γ is required for viral clearance from central nervous system oligodendroglia
57. Mig and IP-10: CXC chemokines that target lymphocytes
58. Requirement of the chemokine receptor CXCR3 for acute allograft rejection
59. Chemokines and cell migration in secondary lymphoid organs
60. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
61. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis
62. CC chemokine receptor (CCR)2 is required for Langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells: Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, β cell outgrowth, and sustained neutrophilic inflammation
63. Cutting edge: Selective usage of chemokine receptors by plasmacytoid dendritic cells
64. Flexibility and cooperation among dendritic cells
65. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1
66. Molecular cloning and structure of a pre-B-cell growth-stimulating factor
67. The earliest stages of B cell development require a chemokine stromal cell-derived factor/pre-B cell growth-stimulating factor
68. + T cell activation
69. Coregulation of CXC chemokine receptor and CD4 expression on T lymphocytes during allogeneic activation
70. Signal transduction by the chemokine receptor CXCR3: Activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes